These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6115432

  • 21. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
    Connolly TM, Limbird LE.
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
    [Abstract] [Full Text] [Related]

  • 22. Phenylbutazone inhibition of equine platelet function.
    Meyers KM, Lindner C, Katz J, Grant B.
    Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Collagen-induced platelet aggregation: evidence of several mechanisms for the induction of platelet release by collagen.
    Nyman D.
    Thromb Res; 1977 May; 10(5):743-51. PubMed ID: 882960
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Acetylenic analog of arachidonate that acts like aspirin on platelets.
    Willis AL, Kuhn DC, Weiss HJ.
    Science; 1974 Jan 25; 183(4122):327-30. PubMed ID: 4809077
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. alpha(2A)-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels.
    Keularts IM, van Gorp RM, Feijge MA, Vuist WM, Heemskerk JW.
    J Biol Chem; 2000 Jan 21; 275(3):1763-72. PubMed ID: 10636873
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Platelet activating factor (PAF) causes human platelet aggregation through the mechanism of membrane modulation.
    Rao GH, White JG.
    Prostaglandins Leukot Med; 1982 Oct 21; 9(4):459-72. PubMed ID: 6817343
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG, Littleton JM.
    Thromb Haemost; 1982 Aug 24; 48(1):49-53. PubMed ID: 6813995
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G, Galanti G, Poggesi L, Abbate R, Neri Serneri GG.
    Adv Prostaglandin Thromboxane Res; 1980 Aug 24; 6():317-20. PubMed ID: 6992529
    [No Abstract] [Full Text] [Related]

  • 37. Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets.
    Rao GH, White JG.
    Am J Hematol; 1981 Dec 24; 11(4):355-66. PubMed ID: 7331991
    [Abstract] [Full Text] [Related]

  • 38. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Lawrie AS, Purdy G, Machin SJ, Brown MM.
    Platelets; 2005 Aug 24; 16(5):269-80. PubMed ID: 16011977
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.